SCHEMBL3833189

SCHEMBL3833189

CC(=O)NC[C@H]1CCCN(C(=O)O)C1

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.46
ALDH1A1 P00352 5/20 0.44
MAPT P10636 1/20 0.44
CCR3 P51677 1/20 0.42
EPHX2 P34913 1/20 0.42
KMT2A Q03164 2/20 0.42
ITGB3 P05106 1/20 0.41
ITGA2B P08514 1/20 0.41
LMNA P02545 1/20 0.41
FAP Q12884 2/20 0.40
DPP4 P27487 1/20 0.40
PREP P48147 1/20 0.40
ACKR3 P25106 1/20 0.39
POLB P06746 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3833195 1.00 KDM4E (0.46) KDM4EALDH1A1MAPTCCR3EPHX2
SCHEMBL13853650 0.84 GRM5 (0.47) KDM4EALDH1A1MAPTCCR3EPHX2
SCHEMBL31348898 0.83 ITGB3 (0.43) KDM4EALDH1A1EPHX2KMT2AITGB3
SCHEMBL5901263 0.83 MTNR1A (0.42)
SCHEMBL21625089 0.82 ITGB3 (0.45) KDM4EALDH1A1MAPTEPHX2KMT2A
SCHEMBL17207607 0.81 CCR3 (0.44) KDM4EALDH1A1MAPTCCR3FAP
SCHEMBL14155724 0.81 CCR3 (0.44) KDM4EALDH1A1MAPTCCR3FAP
SCHEMBL14559366 0.81 CCR3 (0.44) KDM4EALDH1A1MAPTCCR3FAP
SCHEMBL2706533 0.81 KDM4E (0.46) KDM4EALDH1A1MAPTEPHX2KMT2A
SCHEMBL17207589 0.80 ACKR3 (0.57) KDM4EALDH1A1MAPTKMT2AACKR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2102171-A1 NEW PYRIDAZINE DERIVATIVES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS Boehringer Ingelheim International GmbH (DE) 2009-09-23 EP disclosed
WO-2008071646-A1 NEW PYRIDAZINE DERIVATIVES WITH MCH ANTAGONISTIC ACTIVITY AND MEDICAMENTS COMPRISING THESE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-06-19 WO disclosed